Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study

Journal of Surgical Research

Volumn 178, Issue 2, 2012, Pages 779-784

  Ji, Jindong ^a   Yuan, Hexing ^a   Wang, Liangliang ^a   Hou, Jianquan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Disease progression; Lymph node dissection; Prostate cancer; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PELVIC LYMPH NODE DISSECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK;

EID: 84869082481     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.06.069     Document Type: Review

References (34)

1. P. Bader, F.C. Burkhard, R. Markwalder, and U.E. Studer Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169 2003 849
2. M.E. Allaf, G.S. Palapattu, B.J. Trock, H.B. Carter, and P.C. Walsh Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer J Urol 172 2004 1840
3. L. Cheng, H. Zincke, M.L. Blute, E.J. Bergstralh, B. Scherer, and D.G. Bostwick Risk of prostate carcinoma death in patients with lymph node metastasis Cancer 91 2001 66
4. S.A. Joslyn, and B.R. Konety Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer Urology 68 2006 121
5. P. Bader, F.C. Burkhard, R. Markwalder, and U.E. Studer Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 168 2002 514
6. S. Daneshmand, M.L. Quek, and J.P. Stein Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results J Urol 172 6Pt 1 2004 2252
7. C.J. Di Blasio, P. Fearn, and H.S. Seo Association between number of lymph nodes removed and freedom from disease progression in patients receiving pelvic lymph node dissection during radical prostatectomy for prostate cancer J Urol 169 2003 456
8. A. Briganti, M.L. Blute, and J.H. Eastham Pelvic lymph node dissection in prostate cancer Eur Urol 54 2009 1251
9. A. Briganti, F.K. Chun, and A. Salonia Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy Eur Urol 49 2006 1019
10. N. Bhatta-Dhar, A.M. Reuther, C. Zippe, and E.A. Klein No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer Urology 63 2004 528
11. D. Weckermann, M. Goppelt, R. Dorn, F. Wawroschek, and R. Harzmann Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≤10 ng/mL and biopsy Gleason score≤6, and their influence on PSA progression-free survival after radical prostatectomy BJU Int 97 2006 1173
12. A.V. D'Amico, D. Schultz, and M. Loffredo Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer JAMA 284 2000 1280
13. M. Golimbu, P. Moralis, and S. Al-Askari Extended pelvic lymphadenectomy on prostatic cancer J Urol 121 1979 617
14. L.A. Gervasi, J. Mata, and J.D. Easley Prognostic significance of lymph nodal metastases in prostate cancer J Urol 142 1989 332
15. A. Heidenreich, Z. Varga, and R. Von Knobloch Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis J Urol 167 2002 1681
16. M. Han, A.W. Partin, and C.R. Pound Long-term biochemical disease free and cancer specific survival following anatomic radical retropubic prostatectomy: the 15- year Johns Hopkins experience Urol Clin North Am 28 2001 555
17. N.N. Stone, R.G. Stock, and P. Unger Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques J Urol 158 1997 1891
18. F. Wawroschek, H. Vogt, and H. Wengenmair Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer Urol Int 70 2003 303
19. J.L. Tenaglia, and M. Iannucci Extended pelvic lymphadenectomy for the treatment of localized prostate carcinoma Eur Urol Today 2004 15
20. A. Heidenreich, C.H. Ohlmann, and S. Polyakov Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy Eur Urol 52 2007 29
21. G.D. Steinberg, J.I. Epstein, S. Piantadosi, and P.C. Walsh Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987 J Urol 144 1990 14
22. D.S. DiMarco, H. Zincke, T.J. Sebo, J. Slezak, E.J. Bergstralh, and M.L. Blute The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era J Urol 173 2005 1121
23. J. Chin, J. Srigley, and L.A. Mayhew Guideline for optimization of surgical and pathological quality performance for radical prostatectomy in prostate cancer management: surgical and pathological guidelines Can Urol Assoc J 4 2010 13
24. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68
25. G.D. Grossfeld, J.J. Chang, and J.M. Broering Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the cancer of the prostate strategic urologic research endeavor database J Urol 165 2001 851
26. A. Briganti, F.K. Chun, and A. Salonia Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer Eur Urol 50 2006 1006
27. A. Briganti, F.K. Chun, and A. Salonia A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer Eur Urol 51 2007 112
28. J. Walz, F. Bladou, and B. Rousseau Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection Urology 79 2012 546
29. A. Briganti, A. Larcher, and F. Abdollah Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores Eur Urol 6 2012 480
30. D. Weckermann, F. Wawroschek, and R. Harzmann The sentinel lymph node concept in prostate cancer - First results of gamma probe-guided sentinel lymph node identification Eur Urol 36 1999 595
31. D. Weckermann, F. Wawroschek, and R. Harzmann Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy? Eur Urol 47 2005 45
32. M.L. Blute, E.J. Bergstralh, and A.W. Partin Validation of parting tables for predicting pathological stage of clinically localized prostate cancer J Urol 164 2000 1591
33. S.F. Shariat, C.G. Roehrborn, and J.D. McConnell Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis J Clin Oncol 25 2007 349
34. A. Salonia, A. Briganti, and A. Gallina Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection Urology 3 2009 850